Rapid Micro Biosystems (RPID)
(Delayed Data from NSDQ)
$0.90 USD
+0.01 (1.37%)
Updated Oct 4, 2024 12:45 PM ET
3-Hold of 5 3
D Value C Growth B Momentum C VGM
Price, Consensus and EPS Surprise
RPID 0.90 +0.01(1.37%)
Will RPID be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for RPID based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for RPID
What's in Store for Cooper Companies (COO) in Q3 Earnings?
Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Tops Revenue Estimates
RPID: What are Zacks experts saying now?
Zacks Private Portfolio Services
Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates
Edwards Lifesciences (EW) Q1 Earnings and Revenues Top Estimates
Rapid Micro Biosystems, Inc. (RPID) Reports Q3 Loss, Tops Revenue Estimates
Other News for RPID
Rapid Micro Biosystems to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Morgan Stanley Remains a Hold on Rapid Micro Biosystems (RPID)
Rapid Micro Biosystems Inc (RPID) Q2 2024 Earnings Call Transcript Highlights: Record Revenue ...
Buy Rating Affirmed for Rapid Micro Biosystems Amid Strong Revenue Growth and Strategic Cost-Saving Initiatives
Rapid Micro Biosystems, Inc. (RPID) Q2 2024 Earnings Call Transcript